tradingkey.logo
tradingkey.logo
Search

Odyssey Therapeutics Ord Shs (Proposed)

ODTX
Add to Watchlist
18.930USD
+0.510+2.77%
Close 07-31 16:00ETQuotes delayed by 15 min
909.23MMarket Cap
LossP/E TTM

ODTX Financials

See Odyssey Therapeutics Ord Shs (Proposed)'s financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Odyssey Therapeutics Ord Shs (Proposed) Earnings Date

Latest Release
Jun 19, 2026
EPS / Forecast
-6.77/-1.25
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
2.98M
--
EPS(YoY)
-3.15
--
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2024Q4
FY2024Q3
Financial Indicators
EPS
---0.81
---0.76
---0.01
Revenue
--0.00
--1.75M
----
Net Profit
---38.26M
---35.93M
----
Net Margin
----
---2047.41%
---3437.21%
Gross Margin
----
--100.00%
--100.00%
Revenue
--0.00
--1.75M
----
Operating profit
---39.67M
---37.12M
----
Net Profit
---38.26M
---35.93M
----
Current assets
--185.10M
--135.51M
--159.83K
Total current liabilities
--22.21M
--28.41M
--25.11K
Total assets
--229.07M
--197.44M
--221.53K
Total liabilities
--49.21M
--65.07M
--62.59K
Total equity
--179.86M
--132.37M
--158.95K
Net operating income
---41.03M
---34.29M
----
Net investment
--34.80M
--47.14M
----
Net financing
--484.00K
--6.82M
----

FAQs

What is the total revenue of Odyssey Therapeutics Ord Shs (Proposed)?

According to Odyssey Therapeutics Ord Shs (Proposed)'s FY2025 earnings report, its total revenue reached 2.98M, with a year-on-year change of 2.98M.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.